Venous thromboembolism (VTE) poses a significant morbidity and mortality in a broad
population of patients. As healthcare providers, we are well versed in prophylaxis
of hospitalized patients and considering VTE when a patient presents with common symptoms
and well described risk factors, for example, active malignancy or limited mobility.
The authors of this paper cite 500,000 VTEs per year in the US population, half of
which are attributable to recent hospitalization. The remaining 50% are grouped into
“idiopathic,” yet still pose a threat of pulmonary embolism and overall reduced survival.
Identifying the risk posed by infection in developing VTE may reveal another population
served by thoughtful prophylaxis.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
